Other Content - Ophthalmology Times Europe

ADVERTISEMENT

Other Content

New financing round for dry eye portfolio

24 April 2013

Novaliq has secured €13.9 million in a fifth round of financing for a dry eye portfolio.

High index of suspicion required for SS

01 October 2012

A high index of suspicion is required for underlying Sjögren's syndrome (SS) in patients with clinically significant aqueous-deficient dry eye.

The ideal drop through the eyes of doctors and patients

01 September 2010

Five steps and the criteria for success, as seen through the eyes of patients and their doctors...

Contact induced dry eye

01 September 2010

Understanding the problems of contact lens induced dry eye

Tear cytokine and chemokine analysis and clinical correlations in evaporative-type dry eye disease

17 June 2010

In a sample of moderate evaporative-type dry eye disease patients Enriquez-de-Salamanca et al., elevated five inflammatory molecules. Fracktalkine was demonstrated to be present and elevated in tears in human DED.

Cyclosporine helps prevent progression of dry eye

01 September 2009

A recent study showed that moderate to sever dry eye disease can be best treated with anti-inflammatory medications such as topical cyclosporine. According to one ophthalmologist, cyclosporine can significantly limit progression of dry eye disease and should be considered a 'go-to' therapy for this patient population.

Out with the old and in with the new

01 September 2009

A comparison of an older nanoliter osometer and a newer osometer shows that both devices are effective in measuring tear osmolarity and produce comparable measurements.

Insert improves symptoms and quality of life for patients with dry eye

01 September 2009

The use of hydroxypropyl cellulose can significantly improve the symptoms of dry eye, resulting in increased quality of life.

New options in treating lid wiper epitheliopathy

01 September 2009

An oil-in-water and a corticosteroid were both effective in eliminating the signs and symptoms of lid wiper epitheliopathy after a 1-month active treatment phase in a recent study. Improvement was effectively maintained with the emollient eye drops in all patients over a 12-month period.

Click here